SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.86
−4.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.11x
- Price / sales
- 0.88x
- Price / cash flow
- -0.18x
Enterprise value
- Enterprise value
- $7.7M
- EV / sales
- 5.13x
- EV / EBITDA
- -1.15x
- EV / EBIT
- -0.91x
- Market cap
- $1.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026